BioCentury
ARTICLE | Clinical News

Symbicort budesonide/formoterol: Phase IIIb data

August 22, 2016 7:00 AM UTC

Top-line data from the 6-month, double-blind, international Phase IIIb RISE trial in 1,219 patients ages >=40 with moderate to very severe COPD showed that 2 inhalations of 160/4.5 ug Symbicort budeso...